申请人:THE BOARD OF REGENTS OF THE UNIVERSY OF TEXAS SYSTEM
公开号:US11345659B2
公开(公告)日:2022-05-31
The present disclosure relates to chemical compounds that modulate proteasome activity, pharmaceutical compositions containing such compounds, and use of these compounds and compositions for the treatment of disorders of uncontrolled cellular proliferation such as, for example, a cancer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
本公开涉及调节蛋白酶体活性的化合物、含有此类化合物的药物组合物,以及使用这些化合物和组合物治疗不受控制的细胞增殖紊乱,例如癌症。本摘要旨在作为一种扫描工具,用于在特定技术领域进行搜索,而无意限制本发明。